August 8, 2022
Akoya Reports Second Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q2 2022 revenue $17.9 million, 37% y/y growth Raising FY 2022 revenue guidance range to $71-74 million MARLBOROUGH, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the second quarter...

Continue Reading
July 27, 2022
Akoya to Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be participating in two upcoming investor conferences. UBS Genomics 2.0 and MedTech Innovation Conference Fireside Chat – Brian...

Continue Reading
July 12, 2022
Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022
MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the second quarter of 2022 after the market close on Monday, August 8 th , 2022....

Continue Reading
June 28, 2022
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
The OncoSignature ® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers The OncoSignature ® test will run on Akoya’s PhenoImager™ Solution...

Continue Reading
June 1, 2022
Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting
PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platform MARLBOROUGH, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company ® , will present for the first time, data generated using its...

Continue Reading
May 5, 2022
Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q1 2022 revenue $16.9 million, 38% growth over prior year period Raising FY 2022 revenue guidance range to $70-73 million MARLBOROUGH, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for...

Continue Reading
May 3, 2022
Akoya to Participate at Three Upcoming Investor Conferences
MARLBOROUGH, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming investor conferences. Bank of America 2022 Healthcare Conference Presentation on Tuesday, May 10 th at...

Continue Reading
April 19, 2022
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
Dr. El-Gabry’s extensive leadership experience will be critical to accelerating Akoya’s groundbreaking spatial biomarker research technologies into clinical tools that will impact patient care MARLBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The...

Continue Reading
April 14, 2022
Akoya to Report First Quarter 2022 Financial Results on May 5th, 2022
MARLBOROUGH, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2022 after the market close on Thursday, May 5 th , 2022....

Continue Reading
April 6, 2022
Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022
Company to present industry’s first 100-plex, whole slide dataset for deep spatial phenotyping of the tumor microenvironment The Company will also showcase its novel protein chemistry to accelerate biomarker validation MARLBOROUGH, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc.,...

Continue Reading
Displaying 1 - 10 of 18

Search Investor Relations